A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Tumor Biology

• Publication date

  2010-05-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13277-010-0045-5PMID 20480408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition

  2008influential reference
• Circadian rhythm of human salivary chromogranin A.

  2007cited by this paper
• Biomedical Research

  2007cited by this paper
• Interest of Chromogranin A for diagnosis and follow‐up of endocrine tumours

  2004cited by this paper
• The chromogranin-secretogranin family.

  2003cited by this paper
• Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.

  2001cited by this paper
• Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.

  1997cited by this paper
• Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis.

  1997cited by this paper
• Marked increase in gastric acid secretory capacity after omeprazole treatment.

  1996influential reference
• Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach.

  1995cited by this paper
• The granin family--its role in sorting and secretory granule formation.

  1995cited by this paper
• Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia.

  1994cited by this paper
• Na(+)-K(+)-ATPase alpha 1- and beta 1-subunit degradation: evidence for multiple subunit specific rates.

  1993cited by this paper
• Control of gastric corpus chromogranin A messenger RNA abundance in the rat.

  1993cited by this paper
• The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells.

  1991cited by this paper
• Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker.

  1991cited by this paper
• Ultradian variations of chromogranin A in humans.

  1991cited by this paper
• The granin (chromogranin/secretogranin) family.

  1991cited by this paper
• Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors.

  1991cited by this paper
• Radioimmunoassay of histamine.

  1991cited by this paper
• Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.

  1990cited by this paper
• Effects of sandostatin on plasma chromogranin-A levels in neuroendocrine tumors.

  1989cited by this paper
• The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome.

  1989cited by this paper
• Variable contribution of gastrin to gastric acid secretion after a meal in humans.

  1987cited by this paper
• Gastric acid secretion in the totally isolated, vascularly perfused rat stomach. A selective muscarinic-1 agent does, whereas gastrin does not, augment maximal histamine-stimulated acid secretion.

  1987cited by this paper
• Gastrin produces an immediate and dose-dependent histamine release preceding acid secretion in the totally isolated, vascularly perfused rat stomach.

  1987cited by this paper
• The preparation of bioactive 125I-gastrin, using Iodo-gen as oxidizing agent, and the use of this tracer in receptor studies.

  1985cited by this paper
• Detection of chromogranin in neuroendocrine cells with a monoclonal antibody.

  1984cited by this paper

• Smoking Adversely Affects Survival of Metastatic Lung Carcinoid Patients: Analysis of a Large International Audit and Prognostic Models for Metastasis-Free Survival and Overall Survival

  2025cites this paper
• the acute

  2020cites this paper
• Towards Understanding of Gastric Cancer Based upon Physiological Role of Gastrin and ECL Cells

  2020cites this paper
• Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome

  2020cites this paper
• Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones

  2019cites this paper
• The Role of the Acute Octreotide Suppression Test in Detecting Patients with Neuroendocrine Neoplasms

  2018cites this paper
• Biomarkers of the effect of gastrin on Barrett's oesophagus

  2018cites this paper
• Effects of intake of breakfast or caffeine‐containing beverages on measurement of circulating chromogranin A in plasma

  2018influential citation
• Proton pump inhibitors (PPIs) may cause gastric cancer – clinical consequences

  2018cites this paper
• The clinical characteristics and prognosis of 73 patients with Nonfunctional Gastroenteropancreatic neuroendocrine neoplasm: a 10-year retrospective study of a single center

  2017cites this paper
• Abnormal differentiation of stem cells into enteroendocrine cells in rats with DSS-induced colitis

  2017cites this paper
• Compensation Claims for Sub-substandard Care of Patients with Gastroentero-pancreatic Neuroendocrine Tumors: A Nationwide Descriptive Study of Cases Between 2005-2016 in Norway.

  2017cites this paper
• The effect of the consumed meal and of serum sample freezing/thawing cycles on the chromogranin A (CgA) blood level

  2017cites this paper
• Interaction between diet and gastrointestinal endocrine cells

  2016cites this paper
• The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: review of long-term treatment

  2016cites this paper
• Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms.

  2016cites this paper
• Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls

  2016cites this paper
• Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.

  2015cites this paper
• An investigation of novel biomarkers of gastric mucosal preneoplasia

  2015cites this paper
• Recent advances in the diagnosis of irritable bowel syndrome

  2015cites this paper
• Neuroendocrine Tumor Biomarkers: Current Status and Perspectives

  2014cites this paper
• Is irritable bowel syndrome an organic disorder?

  2014cites this paper
• Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (Review)

  2014cites this paper
• The biochemical utility of chromogranin A, chromogranin B and cocaine- and amphetamine-regulated transcript for neuroendocrine neoplasia

  2014cites this paper
• Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

  2013cites this paper
• The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood

  2013cites this paper
• Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors

  2012cites this paper
• The ECL cell: relay station for gastric integrity.

  2012cites this paper
• Gastric secretion

  2011cites this paper
• Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids

  2011cites this paper